Interactions among genetic variants in apoptosis pathway genes, reflux symptoms, body mass index, and smoking indicate two distinct etiologic patterns of esophageal adenocarcinoma

Journal of Clinical Oncology

Volumn 28, Issue 14, 2010, Pages 2445-2451

  Zhai, Rihong ^a   Chen, Feng ^a   Liu, Geoffrey ^a   Su, Li ^a   Kulke, Matthew H ^a   Asomaning, Kofi ^a   Lin, Xihong ^a   Heist, Rebecca S ^a   Nishioka, Norman S ^a   Sheu, Chau Chyun ^a   Wain, John C ^a   Christiani, David C ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FAS ANTIGEN; FAS LIGAND; INTERLEUKIN 1BETA; PROTEIN P53;

ADULT; APOPTOSIS; ARTICLE; BODY MASS; CANCER RISK; CONTROLLED STUDY; ESOPHAGEAL ADENOCARCINOMA; FEMALE; GASTROESOPHAGEAL REFLUX; GENETIC VARIABILITY; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SINGLE NUCLEOTIDE POLYMORPHISM; SMOKING; ADENOCARCINOMA; AGED; CASE CONTROL STUDY; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; ESOPHAGUS TUMOR; FACTORIAL ANALYSIS; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; MIDDLE AGED; PATHOLOGY; PROSPECTIVE STUDY; RISK; RISK ASSESSMENT; STATISTICAL MODEL;

ADENOCARCINOMA; AGED; APOPTOSIS; BODY MASS INDEX; CASE-CONTROL STUDIES; CHI-SQUARE DISTRIBUTION; ESOPHAGEAL NEOPLASMS; FACTOR ANALYSIS, STATISTICAL; FEMALE; GASTROESOPHAGEAL REFLUX; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIKELIHOOD FUNCTIONS; LOGISTIC MODELS; MALE; MIDDLE AGED; ODDS RATIO; POLYMORPHISM, SINGLE NUCLEOTIDE; PROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 77952513628     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2009.26.2790     Document Type: Article

References (39)

1. Crane SJ, Locke GR 3rd, Harmsen WS, et al: Survival trends in patients with gastric and esophageal adenocarcinomas: A population-based study. Mayo Clin Proc 83:1087-1094, 2008
2. Brown LM, Devesa SS, Chow WH: Incidence of adenocarcinoma of the esophagus among white Americans by sex, stage, and age. J Natl Cancer Inst 100:1184-1187, 2008
3. Pera M, Manterola C, Vidal O, et al: Epidemiology of esophageal adenocarcinoma. J Surg Oncol 92:151-159, 2005 (Pubitemid 41779297)
4. Enzinger PC, Mayer RJ: Esophageal cancer. N Engl J Med 349:2241-2252, 2003 (Pubitemid 37485141)
5. Cheung WY, Liu G: Genetic variations in esophageal cancer risk and prognosis. Gastroenterol Clin North Am 38:75-91, 2009
6. Zhai R, Liu G, Asomaning K, et al: Genetic polymorphisms of VEGF, interactions with cigarette smoking exposure and esophageal adenocarcinoma risk. Carcinogenesis, 29:2330-2334, 2008
7. Cheung WY, Zhai R, Kulke MH, et al: Epidermal growth factor A61G gene polymorphism, gastroesophageal reflux disease and esophageal adenocarcinoma risk. Carcinogenesis 30:1363-1367, 2009
8. Smith KJ, O'Brien SM, Smithers BM, et al: Interactions among smoking, obesity, and symptoms of acid reflux in Barrett's esophagus. Cancer Epidemiol Biomarkers Prev 14:2481-2486, 2005 (Pubitemid 41752705)
9. Whiteman DC, Sadeghi S, Pandeya N, et al: Combined effects of obesity, acid reflux and smoking on the risk of adenocarcinomas of the oesophagus. Gut 57:173-180, 2008 (Pubitemid 351158042)
10. Lagergren J: Controversies surrounding body mass, reflux, and risk of oesophageal adenocarcinoma. Lancet Oncol 7:347-349, 2006
11. Hanahan D, Weinberg RA: The hallmarks of cancer. Cell 100:57-70, 2000 (Pubitemid 30046295)
12. McCabe ML, Dlamini Z: The molecular mechanisms of oesophageal cancer. Int Immunopharmacol 5:1113-1130, 2005 (Pubitemid 40725707)
13. Sun T, Zhou Y, Li H, et al: FASL -844C polymorphism is associated with increased activation-induced T cell death and risk of cervical cancer. J Exp Med 202:967-974, 2005 (Pubitemid 41396896)
14. Ferreira SB Jr, Trombone AP, Repeke CE, et al: An interleukin-1beta (IL-1beta) single-nucleotide polymorphism at position 3954 and red complex periodontopathogens independently and additively modulate the levels of IL-1beta in diseased periodontal tissues. Infect Immun 76:3725-3734, 2008
15. Rudd MF, Webb EL, Matakidou A, et al: Variants in the GH-IGF axis confer susceptibility to lung cancer. Genome Res 16:693-701, 2006 (Pubitemid 43830689)
16. Sibley K, Rollinson S, Allan JM, et al: Functional FAS promoter polymorphisms are associated with increased risk of acute myeloid leukemia. Cancer Res 63:4327-4330, 2003 (Pubitemid 36950998)
17. Zhang B, Sun T, Xue L, et al: Functional polymorphisms in FAS and FASL contribute to increased apoptosis of tumor infiltration lymphocytes and risk of breast cancer. Carcinogenesis 28:1067-1073, 2007 (Pubitemid 47072192)
18. Zhivotovsky B, Orrenius S: Carcinogenesis and apoptosis: Paradigms and paradoxes. Carcinogenesis 27:1939-1945, 2006
19. Sun T, Miao X, Zhang X, et al: Polymorphisms of death pathway genes FAS and FASL in esophageal squamous-cell carcinoma. J Natl Cancer Inst 96:1030-1036, 2004 (Pubitemid 39162646)
20. Ter-Minassian M, Zhai R, Asomaning K, et al: Apoptosis gene polymorphisms, age, smoking and the risk of non-small cell lung cancer. Carcinogenesis 29:2147-2152, 2008
21. Souza RF, Shewmake K, Pearson S, et al: Acid increases proliferation via ERK and p38 MAPK-mediated increases in cyclooxygenase-2 in Barrett's adenocarcinoma cells. Am J Physiol Gastrointest Liver Physiol 287:G743-G748, 2004 (Pubitemid 39280431)
22. Khandwala HM, McCutcheon IE, Flyvbjerg A, et al: The effects of insulin-like growth factors on tumorigenesis and neoplastic growth. Endocr Rev 21:215-244, 2000 (Pubitemid 32275588)
23. Zhong CY, Zhou YM, Joad JP, et al: Environmental tobacco smoke suppresses nuclear factor-kappaB signaling to increase apoptosis in infant monkey lungs. Am J Respir Crit Care Med 174:428-436, 2006 (Pubitemid 44223124)
24. Benjamini Y, Yekutieli D: Quantitative trait Loci analysis using the false discovery rate. Genetics 171:783-790, 2005 (Pubitemid 43156463)
25. Zhang H, Bonney G: Use of classification trees for association studies. Genet Epidemiol 19:323-332, 2000
26. Duell EJ, Bracci PM, Moore JH, et al: Detecting pathway-based gene-gene and gene-environment interactions in pancreatic cancer. Cancer Epidemiol Biomarkers Prev 17:1470-1479, 2008
27. Chen M, Kamat AM, Huang M, et al: High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 28:2160-2165, 2007 (Pubitemid 47543377)
28. Lagergren J, Bergstrom R, Lindgren A, et al: Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 340:825-831, 1999 (Pubitemid 29142625)
29. Chow WH, Finkle WD, McLaughlin JK, et al: The relation of gastroesophageal reflux disease and its treatment to adenocarcinomas of the esophagus and gastric cardia. JAMA 274:474-477, 1995
30. Chow WH, Blot WJ, Vaughan TL, et al: Body mass index and risk of adenocarcinomas of the esophagus and gastric cardia. J Natl Cancer Inst 90:150-155, 1998 (Pubitemid 28114417)
31. Delgado-Aros S, Locke GR 3rd, Camilleri M, et al: Obesity is associated with increased risk of gastrointestinal symptoms: A population-based study. Am J Gastroenterol 99:1801-1806, 2004
32. Saarni SE, Pietiläinen K, Kantonen S, et al: Association of smoking in adolescence with abdominal obesity in adulthood: A follow-up study of 5 birth cohorts of Finnish twins. Am J Public Health 99:348-354, 2009
33. Zhang X, Miao X, Sun T, et al: Functional polymorphisms in cell death pathway genes FAS and FASL contribute to risk of lung cancer. J Med Genet 42:479-484, 2005 (Pubitemid 40847235)
34. Yang M, Sun T, Wang L, et al: Functional variants in cell death pathway genes and risk of pancreatic cancer. Clin Cancer Res 14:3230-3236, 2008
35. Peduzzi P, Concato J, Feinstein AR, et al: Importance of events per independent variable in proportional hazards regression analysis: II. Accuracy and precision of regression estimates. J Clin Epidemiol 48:1503-1510, 1995 (Pubitemid 26035533)
36. Ritchie MD, Hahn LW, Roodi N, et al: Multifactor-dimensionality reduction reveals high-order interactions among estrogen-metabolism genes in sporadic breast cancer. Am J Hum Genet 69:138-147, 2001 (Pubitemid 32614026)
37. Wu X, Gu J, Grossman HB, et al: Bladder cancer predisposition: A multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 78:464-479, 2006 (Pubitemid 43291228)
38. Gauderman WJ: Sample size requirements for association studies of gene-gene interaction. Am J Epidemiol 155:478-484, 2002
39. Ritchie MD, Hahn LW, Moore JH: Power of multifactor dimensionality reduction for detecting gene-gene interactions in the presence of genotyping error, missing data, phenocopy, and genetic heterogeneity. Genet Epidemiol 24:150-157, 2003 (Pubitemid 36158211)